MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

Neurizon Therapeutics has reported positive topline results from an open-label extension study of its lead candidate NUZ-001 ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...

The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

Since 2023, the Inflation Reduction Act (IRA) has capped the cost of insulin for Medicare beneficiaries at $35 per month.

A strong performance from APA’s gas transmission and storage business contributed to a 6.4% lift in EBITDA for the company, ...

The Japanese launch builds on ClearStrand-ASD’s successful rollout across the United States, where it is now available in 49 states. YAC Bio will partner with hospital systems in Japan to facilitate ...

The onset of motor neurone disease (MND) left Sarah without a voice and the use of her hands at the age of 34. It was within ...

Pharmaust Limited ( ($AU:NUZ) ) just unveiled an announcement. Neurizon Therapeutics Limited announced a shareholder webinar scheduled for August ...

Texas senators approved several bills Monday, one of which included another attempt at blocking hemp-derived THC products.

Having lived with an ALS diagnosis since 2018, Kate Nycz can tell you firsthand what it's like to slowly lose motor function ...